Xylem Inc. (NYSE:XYL) Receives $166.90 Consensus Target Price from Analysts

Xylem Inc. (NYSE:XYL) has earned an average rating of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $167.40.

Several research firms have recently issued reports on XYL. Cowen reiterated a “hold” rating on shares of Xylem in a report on Friday. Citigroup lifted their price objective on Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Robert W. Baird set a $178.00 target price on Xylem in a research note on Wednesday, October 29th. Zacks Research downgraded Xylem from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Finally, Stifel Nicolaus upped their price target on shares of Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th.

Xylem Stock Performance

Shares of XYL stock opened at $136.88 on Friday. The company’s fifty day moving average price is $145.53 and its 200-day moving average price is $138.86. The stock has a market cap of $33.33 billion, a PE ratio of 35.19, a price-to-earnings-growth ratio of 2.15 and a beta of 1.18. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. Xylem has a 12 month low of $100.47 and a 12 month high of $154.27.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. During the same period last year, the company posted $1.11 EPS. Xylem’s revenue was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, equities analysts expect that Xylem will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Tuesday, November 25th. Xylem’s dividend payout ratio is currently 41.13%.

Insider Buying and Selling

In related news, Director Victoria D. Harker sold 1,700 shares of the firm’s stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This trade represents a 9.15% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total value of $1,590,661.44. Following the completion of the transaction, the executive vice president directly owned 31,250 shares in the company, valued at $4,770,000. This trade represents a 25.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Xylem

Large investors have recently bought and sold shares of the business. SJS Investment Consulting Inc. lifted its stake in Xylem by 1,844.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock valued at $26,000 after acquiring an additional 166 shares during the period. Knuff & Co LLC purchased a new position in shares of Xylem during the third quarter valued at approximately $27,000. Wexford Capital LP bought a new position in Xylem during the third quarter valued at approximately $27,000. First Horizon Corp purchased a new stake in Xylem in the third quarter worth approximately $30,000. Finally, Ramirez Asset Management Inc. grew its position in Xylem by 100.0% in the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after purchasing an additional 100 shares during the period. 87.96% of the stock is currently owned by institutional investors.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.